SS
RVMD icon

SBI Securities’s Revolution Medicines RVMD Stock Holding History

SBI Securities’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Buy
1,514
+1,405
+1,289% +$205K 0.01% 563
2026
Q1 		$10.6K Sell
109
-5
-4% -$505 ﹤0.01% 1693
2025
Q4 		$9.08K Buy
114
+14
+14% +$918 ﹤0.01% 1750
2025
Q3 		$4.67K Sell
100
-67
-40% -$2.62K ﹤0.01% 2077
2025
Q2 		$6.14K Buy
167
+10
+6% +$384 ﹤0.01% 1892
2025
Q1 		$5.55K Buy
157
+50
+47% +$2.03K ﹤0.01% 1853
2024
Q4 		$4.68K Buy
+107
New +$5.4K ﹤0.01% 1947

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

SBI Securities's RVMD Position: Q2 2026 in Review

SBI Securities increased its Revolution Medicines (RVMD) stake by 1,289% in Q2 2026, buying an estimated $205K and bringing the position to 1,514 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #563.

SBI Securities first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • SBI Securities held 1,514 shares of Revolution Medicines worth $284K as of Q2 2026.
  • SBI Securities bought 1,405 Revolution Medicines shares in Q2 2026, an estimated $205K.
  • Revolution Medicines made up 0.01% of SBI Securities's portfolio in Q2 2026, its #563 holding.
  • SBI Securities first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.